Trial Profile
Safety and tolerability of inhaled treprostinil (iTRE) in patients with pulmonary hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Mar 2017
Price :
$35
*
At a glance
- Drugs Treprostinil (Primary)
- Indications Pulmonary hypertension
- Focus Adverse reactions
- 13 Feb 2015 New trial record